Ticker > Market > NSE > Nifty Pharma

Nifty Pharma

This page shows the latest information about the Nifty Pharma of NSE.

The Nifty Pharma Index contains total of companies which are also called its Constituents.

21839.05 
 -36.25  (-.17%)
Today, 09:54 AM

Nifty Pharma 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Today's Gainer / Loser

Company priceRs. Change%
Divi''s Lab 6164.00 +0.97%
Alkem Laboratories 5528.50 +0.66%
Biocon 349.40 +0.46%
Lupin 1929.80 +0.26%
JB Chem & Pharma 1660.50 +0.23%
Company priceRs. Change%
Gland Pharma 1940.00 -0.02%
Abbott India 29810.00 -0.05%
Mankind Pharma 2474.60 -0.25%
Torrent Pharma 3527.00 -0.28%
Ipca Laboratories 1355.70 -0.3%

Top Performer companies (Based on TTM Profit)

Company TTM ProfitCr.
Sun Pharma Inds. 10411.47
Dr. Reddy''s Lab 5726.70
Cipla 5406.81
Zydus Lifesciences 4637.80
Lupin 3722.18
Aurobindo Pharma 3417.93
Alkem Laboratories 2334.08
Divi''s Lab 2306.00
Torrent Pharma 2002.00
Ajanta Pharma 929.96

Top Return companies 1m 3m 6m 1Yr

Today's Nifty Pharma Price

As of the close of trading on September 18, 2025, the Nifty Pharma index concluded the day at Rs. 22,592.90, marking a strong positive movement. The Nifty Pharma share price today reflects heightened investor interest in the pharmaceutical sector. This rise comes amidst a period of significant domestic and global developments impacting the industry.

For the most current, regularly updated Nifty Pharma share price, please refer to the live ticker section located above on this page. That section provides a real-time share price summary, including the top gainer loser stocks daily.

Nifty Pharma Historical Returns

The Nifty Pharma index performance has shown a mixed but generally positive trend over various timeframes as of September 18, 2025:

  • 1 Week: +0.69%

  • 1 Month: +0.09%

  • 3 Months: +2.86%

  • 6 Months: +7.43%

  • 1 Year: -4.89%

While the index has delivered positive short-term returns over the past week and months, its one-year return is slightly negative. This indicates some short-term volatility and a period of consolidation. However, the multi-month gains suggest that the index is in a recovery phase, with the potential for long-term growth driven by fundamental factors. The historical returns show that the sector can be volatile but holds long-term promise for investors.

Nifty Pharma News and Updates

 

Recent news events have been a major driver for the Nifty Pharma index's performance:

  • US Fed Rate Cut: The US Federal Reserve's recent decision to cut interest rates has significantly boosted the Indian pharma sector. This move has made Indian pharma stocks more attractive to foreign investors, leading to increased capital inflows. As a result, the Nifty Pharma index saw a notable rally on September 18, with several of its constituents, including Sun Pharmaceutical Industries, gaining momentum.

  • Trade Talks with the US: Ongoing trade discussions between India and the US are a key factor to watch. If these talks result in a bilateral trade deal that lowers tariffs on Indian goods, it could provide a significant boost to pharmaceutical exports and improve the profitability of major companies within the index.

  • Corporate Earnings and Performance: The performance of individual stocks within the index, such as Sun Pharma and Biocon, has also influenced the overall index trend. Positive news or a change in outlook from a major brokerage firm can trigger buying interest, thereby affecting the overall Nifty Pharma performance.

Read More
X